ACCEL Lite: Selecting an Oral P2Y12 Inhibitor Post-MI: What’s the Best Choice?
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research - Un pódcast de American College of Cardiology - Martes
Categorías:
In this interview, Francesco Franchi, MD and Spencer B. King III, MD, MACC, with Matt A. Cavender MD, MPH, FACC, discuss how to make the best choice when selecting an oral P2Y12 inhibitor post-MI.
